Title 21

PART 341 SUBPART C

Subpart C - Labeling

• 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.

21:5.0.1.1.19.3.1.1	SECTION 341.70	341.70 Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product).
21:5.0.1.1.19.3.1.2	SECTION 341.72	341.72 Labeling of antihistamine drug products.
21:5.0.1.1.19.3.1.3	SECTION 341.74	341.74 Labeling of antitussive drug products.
21:5.0.1.1.19.3.1.4	SECTION 341.76	341.76 Labeling of bronchodilator drug products.
21:5.0.1.1.19.3.1.5	SECTION 341.78	341.78 Labeling of expectorant drug products.
21:5.0.1.1.19.3.1.6	SECTION 341.80	341.80 Labeling of nasal decongestant drug products.
21:5.0.1.1.19.3.1.7	SECTION 341.85	341.85 Labeling of permitted combinations of active ingredients.
21:5.0.1.1.19.3.1.8	SECTION 341.90	341.90 Professional labeling.

---